- Home
- OMEX vs STRO Comparison
OMEX vs STRO Comparison
Compare OMEX & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMEX
- STRO
- Stock Information
- Founded
- OMEX 1986
- STRO 2003
- Country
- OMEX United States
- STRO United States
- Employees
- OMEX N/A
- STRO 244
- Industry
- OMEX Marine Transportation
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OMEX Consumer Discretionary
- STRO Health Care
- Exchange
- OMEX Nasdaq
- STRO Nasdaq
- Market Cap
- OMEX 82.2M
- STRO 85.6M
- IPO Year
- OMEX N/A
- STRO 2018
- Fundamental
- Price
- OMEX $3.63
- STRO $1.13
- Analyst Decision
- OMEX
- STRO Hold
- Analyst Count
- OMEX 0
- STRO 7
- Target Price
- OMEX N/A
- STRO $1.97
- AVG Volume (30 Days)
- OMEX 4.2M
- STRO 1.2M
- Earning Date
- OMEX 11-12-2025
- STRO 11-12-2025
- Dividend Yield
- OMEX N/A
- STRO N/A
- EPS Growth
- OMEX N/A
- STRO N/A
- EPS
- OMEX N/A
- STRO N/A
- Revenue
- OMEX $620,048.00
- STRO $104,473,000.00
- Revenue This Year
- OMEX N/A
- STRO $65.48
- Revenue Next Year
- OMEX N/A
- STRO N/A
- P/E Ratio
- OMEX $173.68
- STRO N/A
- Revenue Growth
- OMEX N/A
- STRO N/A
- 52 Week Low
- OMEX $0.27
- STRO $0.52
- 52 Week High
- OMEX $4.43
- STRO $4.60
- Technical
- Relative Strength Index (RSI)
- OMEX 65.66
- STRO 69.69
- Support Level
- OMEX $3.13
- STRO $0.77
- Resistance Level
- OMEX $4.43
- STRO $0.89
- Average True Range (ATR)
- OMEX 0.48
- STRO 0.09
- MACD
- OMEX 0.09
- STRO 0.02
- Stochastic Oscillator
- OMEX 68.65
- STRO 91.45
About OMEX Odyssey Marine Exploration Inc.
Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodules (battery metals) projects. Its projects include the ExO Phosphate project, CIC, Ocean Minerals, and the LIHIR Gold project.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.